Michael Moore - Jan 17, 2024 Form 4/A Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
President
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Stock symbol
VMD
Transactions as of
Jan 17, 2024
Transactions value $
-$140,472
Form type
4/A
Date filed
1/26/2024, 03:14 PM
Date Of Original Report
Jan 19, 2024
Previous filing
Aug 16, 2023
Next filing
Jan 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Tax liability -$68.2K -9.22K -7.54% $7.39 113K Jan 17, 2024 Direct F1, F2, F3
transaction VMD Common Shares Options Exercise +9.49K +8.39% 123K Jan 18, 2024 Direct F4, F5
transaction VMD Common Shares Disposed to Issuer -$72.3K -9.49K -7.74% $7.62 113K Jan 18, 2024 Direct F5, F6
holding VMD Common Shares 1.72M Jan 17, 2024 by Moore Faster LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F2 This filing amends the Form 4 originally filed on January 19, 2024, to correct an administrative error in reporting the number of shares withheld by the Company to satisfy the reporting person's tax obligation associated with the vesting of previously reported awards of restricted stock units.
F3 Per share value is based on the market closing price of the common shares for January 17, 2024.
F4 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F5 Amounts beneficially owned have been adjusted to take into account the correction reported in footnote 2.
F6 Per share value is based on the market closing price of the common shares for January 18, 2024.